Dr. Gianni Gromo

Dr. Gianni Gromo

Contact

Dr. Gromo is a well-recognized expert in drug discovery &
development, with proven record of advancing projects from discovery to
proof-­‐of-­‐concept in clinical stage, in various fields. Dr. Gromo
resigned from Roche on November 2012 and set up his own consulting firm
(Gromo Consulting) focusing primarily on research & development
strategies for discovering new medicines. He has played multiple roles
in H­‐La Roche, including Research Head of Global Cardiovascular &
Metabolic Research, as well as  Chair of the Global Metabolic &
Vascular Management Discovery Team in charge of all discovery &
development activities in the CV, Renal & Metabolic Area. 

Dr.
Gromo  has also been a member of the pRED Research Leadership Team in
charge of managing Roche research & development global activities,
the Joint Roche –Chugai Research Committee in charge of coordinating the
discovery portfolio of the 2 companies, and member of the Pharma
Committee of China.

His interests include discovering and
developing medicines and the application of translational research
principles to drug discovery. He has also served as a Scientific Advisor
to CSIRO (the  Australian equivalent  of American NIH with a clear
focus  on  applied sciences), Baker Institute (Melbourne,  Australia),
Integra (Yissum, Israel)  and to  several financial institutions